BACKGROUND: Serum adiponectin, leptin, C-peptide, and homocysteine are indicators for obesity, hyperinsulinemia, and chronic inflammation, which have all been associated with colorectal cancer. AIMS: To determine whether serum adiponectin, leptin, C-peptide, and homocysteine are associated with fat, fiber, fruit and vegetable, flavonol, or dry bean intake and colorectal adenoma recurrence. METHODS: Using logistic regression, we estimated odds ratios (OR) and 95% confidence intervals (95% CI) for adenoma recurrence in 627 participants from the control arm of the Polyp Prevention Trial, a 4-year trial that examined the effectiveness of a low-fat, high-fiber, high-fruit and vegetable diet on adenoma recurrence. RESULTS: Serum concentrations of C-peptide and homocysteine were inversely related to fiber, fruit and vegetable, and flavonol intake and positively related to percentage of calories from fat (all P(trend) < or = 0.01). High homocysteine concentrations were associated with any (4th versus 1st quartile: OR, 2.26; 95% CI, 1.30-3.94) and more than one adenoma recurrence (OR, 2.11; 95% CI, 1.01-4.40). Individuals in the highest, versus lowest, tertile of serum leptin concentration had a decreased risk of advanced adenoma recurrence (OR, 0.22; 95% CI, 0.06-0.79). CONCLUSION: Our results suggest that serum homocysteine may serve as an indicator of dietary exposure, including a low-fat and high-fiber, high-fruit and vegetable, and high-flavonol diet, as well as colorectal adenoma recurrence. IMPACT: Discovering biomarkers that are both modifiable and can predict cancer risk is critical. We identified serum homocysteine as a novel indicator that is modified by diet and predicts risk of adenoma recurrence. Copyright 2010 AACR.
BACKGROUND: Serum adiponectin, leptin, C-peptide, and homocysteine are indicators for obesity, hyperinsulinemia, and chronic inflammation, which have all been associated with colorectal cancer. AIMS: To determine whether serum adiponectin, leptin, C-peptide, and homocysteine are associated with fat, fiber, fruit and vegetable, flavonol, or dry bean intake and colorectal adenoma recurrence. METHODS: Using logistic regression, we estimated odds ratios (OR) and 95% confidence intervals (95% CI) for adenoma recurrence in 627 participants from the control arm of the Polyp Prevention Trial, a 4-year trial that examined the effectiveness of a low-fat, high-fiber, high-fruit and vegetable diet on adenoma recurrence. RESULTS: Serum concentrations of C-peptide and homocysteine were inversely related to fiber, fruit and vegetable, and flavonol intake and positively related to percentage of calories from fat (all P(trend) < or = 0.01). High homocysteine concentrations were associated with any (4th versus 1st quartile: OR, 2.26; 95% CI, 1.30-3.94) and more than one adenoma recurrence (OR, 2.11; 95% CI, 1.01-4.40). Individuals in the highest, versus lowest, tertile of serum leptin concentration had a decreased risk of advanced adenoma recurrence (OR, 0.22; 95% CI, 0.06-0.79). CONCLUSION: Our results suggest that serum homocysteine may serve as an indicator of dietary exposure, including a low-fat and high-fiber, high-fruit and vegetable, and high-flavonol diet, as well as colorectal adenoma recurrence. IMPACT: Discovering biomarkers that are both modifiable and can predict cancer risk is critical. We identified serum homocysteine as a novel indicator that is modified by diet and predicts risk of adenoma recurrence. Copyright 2010 AACR.
Authors: B J Caan; E Lanza; A Schatzkin; A O Coates; B K Brewer; M L Slattery; J R Marshall; A Bloch Journal: Public Health Nutr Date: 1999-12 Impact factor: 4.022
Authors: J B Meigs; P F Jacques; J Selhub; D E Singer; D M Nathan; N Rifai; R B D'Agostino; P W Wilson Journal: Diabetes Care Date: 2001-08 Impact factor: 19.112
Authors: E Lanza; A Schatzkin; C Daston; D Corle; L Freedman; R Ballard-Barbash; B Caan; P Lance; J Marshall; F Iber; M Shike; J Weissfeld; M Slattery; E Paskett; D Mateski; P Albert Journal: Am J Clin Nutr Date: 2001-09 Impact factor: 7.045
Authors: R Kaaks; P Toniolo; A Akhmedkhanov; A Lukanova; C Biessy; H Dechaud; S Rinaldi; A Zeleniuch-Jacquotte; R E Shore; E Riboli Journal: J Natl Cancer Inst Date: 2000-10-04 Impact factor: 13.506
Authors: Pär Stattin; Annekatrin Lukanova; Carine Biessy; Stefan Söderberg; Richard Palmqvist; Rudolf Kaaks; Tommy Olsson; Egil Jellum Journal: Int J Cancer Date: 2004-03 Impact factor: 7.396
Authors: Stephen D Hursting; Laura M Lashinger; Karrie W Wheatley; Connie J Rogers; Lisa H Colbert; Nomeli P Nunez; Susan N Perkins Journal: Best Pract Res Clin Endocrinol Metab Date: 2008-08 Impact factor: 4.690
Authors: Teresa T Fung; Frank B Hu; Matthias Schulze; Michael Pollak; Tianying Wu; Charles S Fuchs; Edward Giovannucci Journal: Cancer Causes Control Date: 2012-04-26 Impact factor: 2.506
Authors: Matthew F Buas; Haiwei Gu; Danijel Djukovic; Jiangjiang Zhu; Lynn Onstad; Brian J Reid; Daniel Raftery; Thomas L Vaughan Journal: Metabolomics Date: 2017-01-20 Impact factor: 4.290
Authors: Joshua W Miller; Shirley A A Beresford; Marian L Neuhouser; Ting-Yuan David Cheng; Xiaoling Song; Elissa C Brown; Yingye Zheng; Beatriz Rodriguez; Ralph Green; Cornelia M Ulrich Journal: Am J Clin Nutr Date: 2013-02-20 Impact factor: 7.045
Authors: Sarah S Comstock; Diana Xu; Kari Hortos; Bruce Kovan; Sarah McCaskey; Dorothy R Pathak; Jenifer I Fenton Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-06-24 Impact factor: 4.254
Authors: Fred K Tabung; Weike Wang; Teresa T Fung; Frank B Hu; Stephanie A Smith-Warner; Jorge E Chavarro; Charles S Fuchs; Walter C Willett; Edward L Giovannucci Journal: Br J Nutr Date: 2016-11-08 Impact factor: 3.718